ALPL and Miyoshi myopathy: The decrease in ALPL, induced by EVs, and specifically by miR-129-5p, supports the role of EV-miRNAs in MM bone disease.In fact, alkaline phosphatase is decreased in the serum of patients with MM bone involvement [66], while an increase in its level, in patients treated with bortezomib, was associated with treatment response [67].